Stericycle Inc.

Stericycle Inc., a for-profit subsidiary of Waste Management Holdings, Inc. headquartered in Bannockburn, Illinois, operates as a prime contractor providing regulated medical waste removal, pharmaceutical and controlled substance disposal, biohazardous waste handling, and secure document shredding services to federal agencies across civilian and defense sectors on a full-and-open competitive basis—no set-aside activity.

Stericycle competes entirely as a large business across a diversified federal customer base. The vendor's concrete capability footprint spans medical and biohazardous waste disposal (sharps, red bag waste, trace chemotherapy materials), pharmaceutical waste collection and destruction (including DEA controlled substances), infectious waste removal, regulated foreign garbage handling, and secure document shredding and information destruction. Representative named work includes a $2.5 million indefinite delivery contract with the VA Northern California Health Care System (VANCHCS) for biohazardous waste removal services through July 2029; a $1.75 million single-award IDC with VA Veterans Integrated Service Network 2 for sharps and controlled substance destruction through June 2030; a $325,633 five-year definitive contract with Air Mobility Command for regulated foreign garbage management at Joint Base Charleston, South Carolina; a $458,868 purchase order with the Defense Health Agency for controlled substance waste disposal at Naval Medical Center San Diego; and a $707,382.72 contract with VA Veterans Integrated Service Network 23 for hazardous waste pickup and DEA drug waste at the Fargo VA Health Care System and affiliated clinics through June 2030.

Customer concentration is moderate and defense-weighted by dollar value. The top five customer agencies by award count account for 37 percent of recent awards: the Indian Health Service (572 awards, $11 million combined potential value), Army Medical Command (455 awards, $35.3 million), VA VISN 22 (65 awards, $7.3 million), Naval Sea Systems Command (66 awards, $2 million), and Federal Medical Center Devens Bureau of Prisons (94 awards, $1.7 million). By potential value, Army Medical Command dominates at $35.3 million across 455 orders, followed by IHS at $11 million, VA VISN 22 at $7.3 million, and VA VISN 2 at $6.6 million. The rankings signal that Stericycle anchors significant dollar value with Army healthcare operations while maintaining broad task-order volume across civilian health agencies.

Stericycle holds multiple large indefinite delivery contracts and blanket purchase agreements serving as parent vehicles. The top vehicles by task order count include Army Medical Command IDC W81K0415D0017 (181 task orders, $5.5 million combined potential value), IDC W81K0409D0108 (169 task orders, $6.3 million), IDC W81K0405D0008 (77 task orders, $2.9 million), Bureau of Prisons IDC DJBP020500000010 (60 task orders, $251 thousand), and an Indian Health Service BPA (40 task orders, $67 thousand). The vendor also holds single-award BPAs with U.S. Customs and Border Protection for agricultural waste removal ($140,000 ceiling through January 2027) and regulated and non-hazardous waste disposal ($400,000 ceiling through August 2028), a Federal Emergency Management Agency BPA for shred bin rental and weekly shredding in disaster operations ($250,000 original ceiling, since modified), and a Department of Defense Southeast Region IDC for international regulated waste management ($130,000 ceiling through August 2030).

Activity trajectory shows volatility with modest recent decline. Award counts per year tracked: 62 awards in 2022, 39 in 2023, 33 in 2024, 39 in 2025, and 17 in 2026 (through early July). The combined potential value across all 3,422 prime awards in the source data is $163.6 million, with $78.5 million obligated to date (48 percent). Thirty awards with ultimate completion dates in the next twenty-four months carry combined potential value of $2.5 million, representing modest recompete exposure.

Service Contract Inventory data show minimal SCI reporting activity. Across FY2022–FY2024, Stericycle reported zero prime SCI-reportable invoiced revenue; the six SCI-reportable prime records and 22 sub records together show negligible FTE activity (0.1 FTEs in FY2022, 0.0 in FY2023, 0.9 in FY2024). This reflects the fact that Stericycle's federal business consists predominantly of goods and product purchases (waste removal equipment, containers, shredding services rendered via purchase orders) below or outside the $150,000 SCI reporting threshold, not labor-hour service contracts. SCI is therefore not a decision-relevant signal for this vendor.

Stericycle operates as a 100 percent prime contractor (3,422 prime awards, zero sub awards in the source footprint), building its own delivery and operational infrastructure rather than subcontracting delivery. The vendor is a wholly owned subsidiary of Waste Management Holdings, Inc., a diversified parent with multiple named subsidiaries including Shred-It USA LLC (document destruction), Strong Environmental, Inc., and Enserv, LLC, reflecting the parent's broader waste and environmental services portfolio.

The vendor's federal market position is anchored to Army Medical Command healthcare waste requirements, Department of Veterans Affairs sharps and pharmaceutical waste management, Indian Health Service biohazard disposal at tribal healthcare facilities, Bureau of Prisons medical waste handling at correctional and medical centers, and Defense Health Agency pharmaceutical waste programs. Stericycle competes in full-and-open competitions under established indefinite delivery vehicles, winning task orders on technical capability, past performance, and pricing for specialized waste streams where regulatory compliance and operational continuity drive federal procurement behavior.